"Chemokine CXCL13" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that is chemotactic for B-LYMPHOCYTES. It has specificity for CXCR5 RECEPTORS.
| Descriptor ID |
D054382
|
| MeSH Number(s) |
D12.644.276.374.200.120.650 D12.776.467.374.200.120.650 D23.125.300.120.650 D23.469.200.120.650 D23.529.374.200.120.650
|
| Concept/Terms |
Chemokine CXCL13- Chemokine CXCL13
- CXCL13, Chemokine
- SCYB13 Chemokine
- Chemokine, SCYB13
- Chemokine (C-X-C Motif) Ligand 13 (B-Cell Chemoattractant)
- CXCL13 Chemokine
- Chemokine, CXCL13
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL13".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL13".
This graph shows the total number of publications written about "Chemokine CXCL13" by people in this website by year, and whether "Chemokine CXCL13" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 2 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemokine CXCL13" by people in Profiles.
-
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients. Nat Commun. 2021 08 09; 12(1):4888.
-
Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection. mSphere. 2021 01 20; 6(1).
-
Bone Marrow Infiltration of Angioimmunoblastic T-Cell Lymphoma: Identification and Prognostic Impact of Histologic Patterns and Diagnostic Application of Ancillary Phenotypic and Molecular Analyses. Arch Pathol Lab Med. 2020 05; 144(5):602-611.
-
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children. Front Immunol. 2019; 10:1497.
-
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population. Breast Cancer Res. 2018 02 26; 20(1):15.
-
Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis. Eur Respir J. 2017 04; 49(4).
-
Interleukin-1ß pre-treated bone marrow stromal cells alleviate neuropathic pain through CCL7-mediated inhibition of microglial activation in the spinal cord. Sci Rep. 2017 02 14; 7:42260.
-
CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis. Brain Behav Immun. 2016 May; 54:128-139.